Vector Science and Therapeutics Corp. Appoints Angus Jackson as Managing Director of Corporate Development
Why this matters
Commercial real estate continues to digest a multi-year reset in cost of capital. Transaction velocity is below the 2019-2021 trend but improving, cap rates have stabilized across most stabilized property types, and the bid-ask gap has narrowed materially in the past two quarters. Sponsors with permanent capital and operating platforms have an advantage in the current execution environment. The next twelve months will continue to reward underwriting discipline and operational sophistication over balance-sheet aggression.
Editorial analysis · Real Estate Trail Editorial
Jackson to lead organic and inorganic growth initiatives, strategic partnerships and corporate development as the Company advances its life sciences and therapeutics platforms TORONTO, Oct. 19, 2026 /PRNewswire/ -- Ve…
External link. Real Estate Trail does not republish source content.
More from the wire
San Jose Adds 15,000 Jobs in 2026, but Only About 1,000 Fill Office Desks
The San Jose metro is forecast to grow employment 1.3 percent this year, yet Marcus & Millichap expects office-using sectors to contribute only about 1,000 positions after losing roughly 32,000 white-collar jobs in 20…
Craig Panzirer, Rudin’s Head of Leasing, Leans Into His Hard-Won Reputation
When the New York Yankees ask you to join the starting lineup, you say yes. To Craig Panzirer, getting offered a chance to work as senior vice president and head of leasing at Rudin was that kind of opportunity. Panzi…
The warning signs an agent may leave your brokerage — and what to do about them
Findings suggest retention requires more than monitoring sales and adjusting commission structures
Boston, Houston firms team up to buy North Hills property
Clinical ink Announces Strategic Investment from Ardan Equity and GI Partners to Accelerate Next Phase of Growth
Ardan and GI to bring deep, complementary domain expertise across life sciences and healthcare technology and partner with management to further accelerate Clinical ink's growth WINSTON-SALEM, N.C., Oct. 19, 2026 /PRN…